Recent Progress in the Neoadjuvant Treatment Strategy for Locally Advanced Esophageal Cancer

SIMPLE SUMMARY: Neoadjuvant therapy is recommended as standard care for patients with locally advanced resectable esophageal cancer. Neoadjuvant chemotherapy (nCT) and chemoradiotherapy (nCRT) have convincingly been shown to improve the survival rate compared with surgery alone based on the results...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Sicong, Pan, Ziyin, Hao, Xin, Hang, Qinglei, Ding, Yanbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533976/
https://www.ncbi.nlm.nih.gov/pubmed/34680311
http://dx.doi.org/10.3390/cancers13205162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533976/
https://www.ncbi.nlm.nih.gov/pubmed/34680311
http://dx.doi.org/10.3390/cancers13205162

Ejemplares similares